Quest Diagnostics
DGX · NYSE · USD · Healthcare
1What is happening
Quest Diagnostics has fallen 1% since its 6-week high on 05/11/2026. How it continues – phase and signs – you see with a free account.
Free account · 3 stocks and coins a dayfrom the 6-week high-1.3%
Other view · 15 analystsHorizon: 12 months9 Buy · 8 Hold · 0 Sell2Our assessment
No dip28How it continues – phase and signs – you see with a free account.
3Your next step
Marking places no order – it only helps you keep track.
More details · reasons, figures, alerts
How deep is the dip?
- from the 6-week high-1.3%
Highest daily price: $259.00 on 05/11/2026 · reference of the assessment · also the highest of the last 3 months
- from the 52-week high-1.3%
Highest price in 52 weeks: $259.00 (Yahoo)
What analysts expect
15 analysts disagree. They look about 12 months ahead – DipCatcher only 14 trading days.
- Buy
- 953 %
- Hold
- 847 %
- Sell
- 00 %
Average price target$257.27
$235.00 to $279.00 · today $255.63
$235.00Ø $257.27$279.00
What is a price target?
The price an analyst expects in about 12 months. Estimates are often far apart and change frequently.
Third-party opinion, not an assessment by DipCatcher. Source: public analyst estimates, as of 08/11/2026. Not financial advice.
The company in figures
- Market value
- 28.2 bn $
- All shares together at the current price.
- P/E
- 25.5
- Price divided by earnings per share, last 12 months.
- Dividend yield
- 1.35 %
- Yearly dividend relative to the price.
- 52-week range
- $171.18 – $259.00
- Lowest and highest price of the last year.
Catalysts
42 h ago- News, last 10 days
- no recent news
- Next earnings
- —
- Last report
- 22/10/2026 +4.4% vs estimate
Key figures
- Market value
- 28.2 bn $Large cap
- P/E
- 25.5
- Dividend yield
- 1.35 %
- Volume today
- 0.9 × Øabout usual
- Beta
- 0.55swings less than the market
- 52-week range
- $171.18 – $259.00price at 96 % of the range
About Quest Diagnostics
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
- Headquarters:
- Secaucus, United States
- 52-week range:
- $171.18 – $259.00
- Website:
- questdiagnostics.com
Trade levels
Why the engine says so
History for this stock or coin
Watch and alert
See which stocks they are
The engine is watching these dips right now. A free account shows the names and opens 3 full analyses a day.
- 3 full analyses a dayWith entry, target, stop and the reasons behind them.
- WatchlistFollow the stocks you care about.
Free, no payment details.
Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search
Not investment advice. Investing carries risk up to total loss.